Literature DB >> 9127799

Blunt renal traumas: contribution of spiral CT with three dimensional reconstruction to the surgical decision process?

L A Michel1, M Lacrosse, L Decannière, F Lorge, A Rosière, P Vandenbossche, J P Trigaux.   

Abstract

Spiral CT has proved to be a valuable tool by providing various kinds of three-dimensional (3D) images of the studied structures. Such 3D images, which offer a more realistic depiction of the lesions, could be of interest for surgeons who are attempting to treat conservatively blunt abdominal traumas and lead to less inappropriate triage between conservative and operative management particularly for renal trauma. A good working relationship between surgeons and radiologists allowed us to perform an early follow-up 3D spiral CT on a commercially available spiral CT scanner. In the first adult patient, the 3D CT demonstrated minor spleen injury associated with severe lacerations of the left kidney with complete separation of the kidney lower pole. A delayed partial lower nephrectomy was performed. For the second 12-year-old patient presenting with severe spleen trauma and macroscopic hematuria, the 3D CT accurately documented the spleen and renal lesions that were safely amenable to nonoperative treatment. For hemodynamically stable patients, 3D CT is a potentially helpful addition to conventional axial CT for quantifying blunt renal traumas and for making the strategic choice between nonoperative, emergency or delayed surgical treatment.

Entities:  

Mesh:

Year:  1996        PMID: 9127799

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  2 in total

1.  Anatomic anomaly in renal blunt trauma.

Authors:  Ching-Fang Wu; Chun-Chieh Huang; Chin-Chi Kuo; Che-Hsiung Wu; Tze-Wah Kao
Journal:  CMAJ       Date:  2010-01-04       Impact factor: 8.262

Review 2.  Review of the evidence on the management of blunt renal trauma in pediatric patients.

Authors:  Jason D Fraser; Pablo Aguayo; Daniel J Ostlie; Shawn D St Peter
Journal:  Pediatr Surg Int       Date:  2009-01-08       Impact factor: 1.827

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.